von Willebrand's disease in Mexico: a pilot study

被引:7
|
作者
Majluf-Cruz, A. [1 ]
Velez-Ruelas, M. A. [2 ]
Gonzalez-Avila, A. I. [3 ]
Garcia-Chavez, J. [4 ]
Berges, A. [5 ]
Lopez-Santiago, N. [6 ]
Monroy-Garcia, R. [1 ]
Moreno-Hernandez, M. [1 ]
Corona-De La Pena, N. [1 ]
Alvarado-Moreno, J. A. [1 ]
Isordia-Salas, I. [1 ]
Hernandez-Juarez, J. [1 ]
机构
[1] Inst Mexicano Seguro Social, UIM Trombosis Hemostasia & Aterogenesis, Mexico City, DF, Mexico
[2] Federac Hematol AC, Mexico City, DF, Mexico
[3] Inst Mexicano Seguro Social, HGR Carlos MacGregor, Dept Hematol, Mexico City, DF, Mexico
[4] UMAE Hosp Especialidades, CMN La Raza, Dept Hematol, Inst Mexicano Seguro Social, Mexico City, DF, Mexico
[5] UMAE Hosp Gen, CMN La Raza, Dept Hematol, Inst Mexicano Seguro Social, Mexico City, DF, Mexico
[6] Inst Nacl Pediat, Dept Hematol, Mexico City, DF, Mexico
关键词
Mexico; prevalence; von Willebrand factor; von Willebrand's disease; HUMAN VONWILLEBRAND-FACTOR; PREVALENCE; DIAGNOSIS;
D O I
10.1111/hae.12016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
von Willebrand's disease (VWD) is the most commonly inherited bleeding disorder. For a long time, it has been said that VWD was absent in some countries due to ethnical differences. Information about the prevalence of VWD in Mexico remains unclear, owing largely to poor awareness and diagnosis of the disease. The aim of this study was to objectively diagnose VWD in a cohort of highly selected Mexican patients with a chronic history of bleeding. Mexican Mestizos were recruited between July 2010 and August 2011. Included were 133 adult and paediatric patients with a high suspicion of VWD. Fifty-three were diagnosed with VWD: 47 (88.7%) with type 1 VWD, four (7.5%) with type 2a VWD and two (3.8%) with type 3 VWD. Mean age for female patients was 19.5years (range 344years) and 18.5years (range 463years) for male patients. Mean age at start of bleeding symptoms was 8.8years (range 161). The most frequent clinical symptoms were epistaxis (84.9%), ecchymosis (79.2%), haematomas (71.7%), gum bleeds (62.3%) and petechia (50.9%). Severe transoperative or postoperative bleeding was found in 17 patients (32.1%). Twenty-six women at childbearing age had a history of abnormal gynaecological bleeding. Our results clearly demonstrate the presence of VWD in Mexican and underscore the importance of a more detailed description of VWD. Efforts to increase the awareness and diagnosis of VWD could help in better identification of patients with bleeding disorders and lead to early, appropriate management with safe and efficacious therapies such as desmopressin and plasma concentrates.
引用
收藏
页码:231 / 235
页数:5
相关论文
共 50 条
  • [31] von Willebrand disease and von Willebrand factor
    Sadler, Brooke
    Castaman, Giancarlo
    O'Donnell, James S.
    HAEMOPHILIA, 2022, 28 : 11 - 17
  • [32] von Willebrand disease in Finland
    Kekomäki, R
    Rasi, V
    Ebeling, F
    Vahtera, E
    Javela, K
    Koski, T
    Myllylä, G
    Ikkala, E
    HAEMOPHILIA, 1999, 5 : 72 - 74
  • [33] Pharmacotherapy of von Willebrand disease
    Franchini, Massimo
    Lippi, Giuseppe
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (06): : 481 - 489
  • [34] von Willebrand disease biology
    Blomback, M.
    Eikenboom, J.
    Lane, D.
    Denis, C.
    Lillicrap, D.
    HAEMOPHILIA, 2012, 18 : 141 - 147
  • [35] von Willebrand disease: a clinical and laboratory study of sixty-five patients
    Chen, Yeu-Chin
    Yang, Luke
    Cheng, Shin-Nan
    Hu, Shu-Hsia
    Chao, Tsu-Yi
    ANNALS OF HEMATOLOGY, 2011, 90 (10) : 1183 - 1190
  • [36] Von Willebrand Disease: An Overview
    Bharati, K. Pavani
    Prashanth, U. Ram
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 73 (01) : 7 - 16
  • [37] Treatment of von Willebrand Disease
    Curnow, Jennifer
    Pasalic, Leonardo
    Favaloro, Emmanuel J.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2016, 42 (02) : 133 - 146
  • [38] MANAGEMENT OF PATIENTS WITH VON WILLEBRAND DISEASE: PRACTICE OF ST. PETERSBURG CITY HEMOPHILIA CARE CENTRE
    Andreeva, T. A.
    Lavrichenko, I. A.
    Klimova, N., I
    Zalepukhina, O. E.
    Konstantinova, V. N.
    Kim, A., V
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2016, 61 (01): : 49 - 53
  • [39] Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
    Leebeek, Frank W. G.
    Peyvandi, Flora
    Escobar, Miguel
    Tiede, Andreas
    Castaman, Giancarlo
    Wang, Michael
    Wynn, Tung
    Baptista, Jovanna
    Wang, Yi
    Zhang, Jingmei
    Mellgard, Bjorn
    Ozen, Gulden
    BLOOD, 2022, 140 (02) : 89 - 98
  • [40] Acquired von Willebrand Syndrome
    Mital, Andrzej
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 25 (06): : 1337 - 1344